非经典型先天性肾上腺增生症队列中基因型特异性皮质醇储备
回顾性分析122例非经典型先天性肾上腺增生症(NCCAH)患者,按基因型分3组,比较ACTH刺激后皮质醇和17-羟孕酮水平及部分皮质醇功能不全发生率。轻/重突变组刺激皮质醇低于轻/轻突变组(480±90 vs 570±125 nmol/L,P<.001),部分皮质醇功能不全比例更高(75% vs 39%,P=.004),峰值17OHP更高(198±92 vs 118±50 nmol/L,P<.001)。
要点
- 轻/重突变组刺激皮质醇480±90 nmol/L,低于轻/轻组570±125 nmol/L(P<.001)。
- 轻/重突变组部分皮质醇功能不全21/28(75%),高于轻/轻组28/71(39%)(P=.004)。
- 轻/重突变组峰值17OHP 198±92 nmol/L,高于轻/轻组118±50 nmol/L(P<.001)。
核心结论
- 轻/重突变组部分肾上腺功能不全发生率高,作者认为该组需仔细权衡停用糖皮质激素治疗的价值及应激覆盖的重要性。
研究设计与样本
- 回顾性评估122例出生后出现男性化并诊断为NCCAH患者的病历资料。
- 患者接受标准静脉0.25 mg/m2 ACTH刺激试验。
- 刺激后17OHP≥40 nmol/L者筛查9种最常见CYP21A2基因突变,随后行多重连接依赖探针扩增。
- 刺激皮质醇水平低于500 nmol/L定义为部分皮质醇功能不全。
主要发现
- 按基因型分3组:77例轻/轻型(主要为p.V281L纯合),29例轻/重突变复合杂合(主要为p.V281L/p.I2Splice),16例p.V281L杂合被排除统计分析。
- 轻/重突变组刺激皮质醇低于轻/轻组(均值±SD,480±90 vs 570±125 nmol/L,P<.001)。
- 轻/重突变组部分皮质醇功能不全比例高于轻/轻组(21/28,75% vs 28/71,39%,P=.004)。
- 轻/重突变组峰值17OHP高于轻/轻组(198±92 vs 118±50 nmol/L,P<.001)。
关键数值与推荐
- 刺激皮质醇水平低于500 nmol/L定义为部分皮质醇功能不全。
- 刺激后17OHP≥40 nmol/L者进入基因筛查流程。
- 近期指南建议NCCAH患者达到成年身高后停用糖皮质激素治疗,但指南未区分NCCAH基因型组。
临床怎么用
- 作者认为轻/重突变组部分肾上腺功能不全发生率高,需仔细权衡停用糖皮质激素治疗的价值。
- 作者认为轻/重突变组应激覆盖具有重要性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Recent guidelines suggest that patients with nonclassic congenital adrenal hyperplasia (NCCAH) stop glucocorticoid therapy after achieving adult height. However, these guidelines do not differentiate between NCCAH genotype groups. OBJECTIVE: Compare ACTH-stimulated cortisol and 17-hydroxyprogesterone (17OHP) levels, and the rate of partial cortisol insufficiency in subjects with NCCAH carrying one mild and one severe (mild/severe) mutation vs subjects with biallelic mild (mild/mild) mutations. METHODS: Retrospective evaluation of the medical records of 122 patients who presented with postnatal virilization and were diagnosed with NCCAH. Patients underwent standard intravenous 0.25 mg/m2 ACTH stimulation testing. Those with stimulated 17OHP level ≥40 nmol/L were screened for the 9 most frequent CYP21A2 gene mutations followed by multiplex ligation-dependent probe amplification. A stimulated cortisol level below 500 nmol/L was defined as partial cortisol deficiency. RESULTS: Patients were subdivided into 3 genotype groups: 77 carried the mild/mild genotype, mainly homozygous for p.V281L mutation; 29 were compound heterozygous for mild/severe mutation, mainly p.V281L/p.I2Splice, and 16 were heterozygous for p.V281L, and were excluded from statistical evaluation. Stimulated cortisol levels were significantly lower in the mild/severe than in the mild/mild group (mean ± SD, 480 ± 90 vs 570 ± 125 nmol/L, P < .001). The mild/severe group exhibited a significantly higher rate of partial cortisol insufficiency (21/28, 75% vs 28/71, 39%, P = .004). Peak 17OHP was significantly higher in the mild/severe group (198 ± 92 vs 118 ± 50 nmol/L, P < .001). CONCLUSION: The high rate of partial adrenal insufficiency in the mild/severe group underscores the need to carefully consider the value of glucocorticoid therapy cessation and the importance of stress coverage in this group.
引用
- Koren I, Weintrob N, Kebesch R, et al. Genotype-Specific Cortisol Reserve in a Cohort of Subjects With Nonclassic Congenital Adrenal Hyperplasia (NCCAH). J Clin Endocrinol Metab. 2024. PMID: 37715965. doi:10.1210/clinem/dgad546
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。